680 related articles for article (PubMed ID: 15039386)
21. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients.
Jarius S; Lechner C; Wendel EM; Baumann M; Breu M; Schimmel M; Karenfort M; Marina AD; Merkenschlager A; Thiels C; Blaschek A; Salandin M; Leiz S; Leypoldt F; Pschibul A; Hackenberg A; Hahn A; Syrbe S; Strautmanis J; Häusler M; Krieg P; Eisenkölbl A; Stoffels J; Eckenweiler M; Ayzenberg I; Haas J; Höftberger R; Kleiter I; Korporal-Kuhnke M; Ringelstein M; Ruprecht K; Siebert N; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B; Rostásy K;
J Neuroinflammation; 2020 Sep; 17(1):262. PubMed ID: 32883358
[TBL] [Abstract][Full Text] [Related]
22. Detection of myelin autoantibodies: evaluation of an assay system for diagnosis of multiple sclerosis in differentiation from other central nervous system diseases.
Langkamp M; Hörnig SC; Hörnig JB; Kirschner M; Pridzun L; Kornhuber ME
Clin Chem Lab Med; 2009; 47(11):1395-400. PubMed ID: 19912047
[TBL] [Abstract][Full Text] [Related]
23. Antibodies against myelin oligodendrocyte glycoprotein in the cerebrospinal fluid of multiple sclerosis patients.
Markovic M; Trajkovic V; Drulovic J; Mesaros S; Stojsavljevic N; Dujmovic I; Mostarica Stojkovic M
J Neurol Sci; 2003 Jul; 211(1-2):67-73. PubMed ID: 12767500
[TBL] [Abstract][Full Text] [Related]
24. Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides.
Ichikawa M; Johns TG; Adelmann M; Bernard CC
Int Immunol; 1996 Nov; 8(11):1667-74. PubMed ID: 8943561
[TBL] [Abstract][Full Text] [Related]
25. Multiple sclerosis: Serum-derived exosomes express myelin proteins.
Galazka G; Mycko MP; Selmaj I; Raine CS; Selmaj KW
Mult Scler; 2018 Apr; 24(4):449-458. PubMed ID: 28273783
[TBL] [Abstract][Full Text] [Related]
26. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein.
O'Connor KC; Appel H; Bregoli L; Call ME; Catz I; Chan JA; Moore NH; Warren KG; Wong SJ; Hafler DA; Wucherpfennig KW
J Immunol; 2005 Aug; 175(3):1974-82. PubMed ID: 16034142
[TBL] [Abstract][Full Text] [Related]
27. Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains.
Tsunoda I; Kuang LQ; Theil DJ; Fujinami RS
Brain Pathol; 2000 Jul; 10(3):402-18. PubMed ID: 10885659
[TBL] [Abstract][Full Text] [Related]
28. Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit.
Silber E; Semra YK; Gregson NA; Sharief MK
Neurology; 2002 May; 58(9):1372-81. PubMed ID: 12011283
[TBL] [Abstract][Full Text] [Related]
29. Antibodies to myelin oligodendrocyte glycoprotein in HIV-1 associated neurocognitive disorder: a cross-sectional cohort study.
Lackner P; Kuenz B; Reindl M; Morandell M; Berger T; Schmutzhard E; Eggers C
J Neuroinflammation; 2010 Nov; 7():79. PubMed ID: 21083890
[TBL] [Abstract][Full Text] [Related]
30. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis.
Bernard CC; Johns TG; Slavin A; Ichikawa M; Ewing C; Liu J; Bettadapura J
J Mol Med (Berl); 1997 Feb; 75(2):77-88. PubMed ID: 9083925
[TBL] [Abstract][Full Text] [Related]
31. Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types.
Greer JM; Trifilieff E; Pender MP
Front Immunol; 2020; 11():1891. PubMed ID: 32973782
[TBL] [Abstract][Full Text] [Related]
32. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.
Jarius S; Pellkofer H; Siebert N; Korporal-Kuhnke M; Hümmert MW; Ringelstein M; Rommer PS; Ayzenberg I; Ruprecht K; Klotz L; Asgari N; Zrzavy T; Höftberger R; Tobia R; Buttmann M; Fechner K; Schanda K; Weber M; Asseyer S; Haas J; Lechner C; Kleiter I; Aktas O; Trebst C; Rostasy K; Reindl M; Kümpfel T; Paul F; Wildemann B;
J Neuroinflammation; 2020 Sep; 17(1):261. PubMed ID: 32883348
[TBL] [Abstract][Full Text] [Related]
33. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls.
Haase CG; Guggenmos J; Brehm U; Andersson M; Olsson T; Reindl M; Schneidewind JM; Zettl UK; Heidenreich F; Berger T; Wekerle H; Hohlfeld R; Linington C
J Neuroimmunol; 2001 Mar; 114(1-2):220-5. PubMed ID: 11240035
[TBL] [Abstract][Full Text] [Related]
34. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
Kerlero de Rosbo N; Hoffman M; Mendel I; Yust I; Kaye J; Bakimer R; Flechter S; Abramsky O; Milo R; Karni A; Ben-Nun A
Eur J Immunol; 1997 Nov; 27(11):3059-69. PubMed ID: 9394837
[TBL] [Abstract][Full Text] [Related]
35. Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis.
Guggenmos J; Schubart AS; Ogg S; Andersson M; Olsson T; Mather IH; Linington C
J Immunol; 2004 Jan; 172(1):661-8. PubMed ID: 14688379
[TBL] [Abstract][Full Text] [Related]
36. Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders.
Reindl M; Khantane S; Ehling R; Schanda K; Lutterotti A; Brinkhoff C; Oertle T; Schwab ME; Deisenhammer F; Berger T; Bandtlow CE
J Neuroimmunol; 2003 Dec; 145(1-2):139-47. PubMed ID: 14644040
[TBL] [Abstract][Full Text] [Related]
37. No association between anti-myelin oligodendrocyte glycoprotein antibodies and serum/cerebrospinal fluid levels of the soluble interleukin-6 receptor complex in multiple sclerosis.
Padberg F; Haase CG; Feneberg W; Schwarz MJ; Hampel H
Neurosci Lett; 2001 Jun; 305(1):13-6. PubMed ID: 11356296
[TBL] [Abstract][Full Text] [Related]
38. The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis.
Stefferl A; Brehm U; Linington C
J Neural Transm Suppl; 2000; (58):123-33. PubMed ID: 11128602
[TBL] [Abstract][Full Text] [Related]
39. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.
Tomassini V; De Giglio L; Reindl M; Russo P; Pestalozza I; Pantano P; Berger T; Pozzilli C
Mult Scler; 2007 Nov; 13(9):1086-94. PubMed ID: 17468447
[TBL] [Abstract][Full Text] [Related]
40. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.
Iglesias A; Bauer J; Litzenburger T; Schubart A; Linington C
Glia; 2001 Nov; 36(2):220-34. PubMed ID: 11596130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
